ADAM9 and neoplasm: The mean survival time of patients with PDAC without cytoplasmic ADAM9 expression was 30 months (±3; median 28±4), compared to 16 months (±2; median 11±1) for those whose tumours showed cytoplasmic ADAM9 expression (P<0.001, Table 3).